iCoreConnect Inc. (NASDAQ:ICCT) Short Interest Down 9.9% in June

iCoreConnect Inc. (NASDAQ:ICCT) was the recipient of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 251,900 shares, a decline of 9.9% from the May 31st total of 279,500 shares. Approximately 3.0% of the company’s shares are short sold. Based on an average trading volume of 370,000 shares, the short-interest ratio is currently 0.7 days.

Institutional Trading of iCoreConnect

A hedge fund recently bought a new stake in iCoreConnect stock. Sapient Capital LLC acquired a new stake in shares of iCoreConnect Inc. (NASDAQ:ICCT) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 31,256 shares of the company’s stock, valued at approximately $39,000. Sapient Capital LLC owned 0.35% of iCoreConnect as of its most recent SEC filing. Institutional investors own 13.42% of the company’s stock.

iCoreConnect Price Performance

ICCT stock traded down $0.03 during midday trading on Wednesday, hitting $0.87. The stock had a trading volume of 3,074 shares, compared to its average volume of 343,420. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.19. iCoreConnect has a 12-month low of $0.12 and a 12-month high of $20.70. The company’s 50-day moving average price is $1.02 and its 200 day moving average price is $1.27.

iCoreConnect (NASDAQ:ICCT) last released its earnings results on Wednesday, May 15th. The company reported ($0.51) EPS for the quarter. The business had revenue of $2.72 million for the quarter.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.